"id","uuid:ID","label","instanceType","name","text","description"
"Objective_1","1eaaa288-628c-4a38-8f39-77c308bc325f","","Objective","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Main objective"
"Objective_2","fd0016f3-1172-411a-bd1f-ab82178d350a","","Objective","OBJ2","To document the safety profile of the xanomeline TTS.","Safety"
"Objective_3","0139fd00-fc94-4eb5-b1fc-7e71ed58cf0a","","Objective","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Behaviour"
